Select Conferences

Peptide Drugs, Overcoming the Challenges, a Growing Business
Mimoun Ayoub and Daniel Scheidegger
Are low-Priced Peptides Affordable?
Rodney Lax and Michael Verlander
Libraries of Conformationally Restricted and Rigid Amino Acids
Igor V. Komarov, Oleksandr O. Grygorenko, Dmytro S. Radchenko, Oleksiy S. Artamonov, Alexander N. Kostyuk, and Andrey A. Tolmachev

SomaLogic and Otsuka Enter Into Research Collaboration
Otsuka to use SomaLogic's aptamer technology to discover and develop research tools to enhance pharmaceutical discovery and development efforts.

PolyMedix Receives Clearance to Initiate Phase I Clinical Study of Systemic Antibiotic Compound
PMX-30063, the company’s first defensin mimetic systemic antibiotic drug cleared for human clinical trials.

Cytopia Announces Novel Anti-Cancer Drug Development Collaboration
Cytopia has out-licensed technology to Cancer Therapeutics for an undisclosed kinase enzyme target with potential for treating metastatic cancers.

ChemAxon Announces new CEO and Head of R&D
Company increases its focus on business development and market position with new appointments.

ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses from Bayer Healthcare
ACT Biotech acquires an anti-angiogenic receptor tyrosine kinase inhibitor entering Phase II clinical studies for colorectal cancer.

3D-QSAR Common Feature Pharmacophore Model for Polyphenols as Potential Anti-Malarial Agents
CDRI

3D QSAR studies have been carried out on a series of polyphenols for their antimalarial activity using CATALYST program. Hypothesis with three features namely hydrophobic (1), hydrogen bond donor (1) and hydrogen bond acceptor (1) was found to the best, which mapped well with the most active and least active compound of the test set. This model can be used to develop drugs for malarial chemotherapy.

SOME BIOLOGICAL PROPERTIES OF TRITERPENOID ACIDS
Saint-Petersburg State University, *Institute of Cytology RAS

Ursolic and betulinic acids acids induce the processes of apoptosis. We tested the risk of osteoporosis induction under influence of triterpenoids, since they can interact with glucocorticoid receptors. In experiments on oviriectomized rats we found that acids do not show any negative influence on percentage of mineral components in the femur and have cholesterol-lowering action under experimental conditions.

THE OSTEOPROTECTIVE ACTION OF 6-OXA-8a-ANALOGUES OF STEROID ESTROGENS
Saint-Petersburg State University

We synthesized fourteen 6-oxa-8a-estrogens analogues and investigated osteoprotective and uterotropic actions. We demonstrated correlation: every modification in structure of 6-oxa-8-analogues leading to strong (>30%) reduction of uterotropic action induces slump of osteoprotective activity. This allows to make conclusion: main biotarget, responsible for appearance of osteoprotective action is a-estrogen receptor. We found steroid estrogen analogues with cholesterol-lowering properties without u

Permanent Senior Scientist Position in NMR-based Metabolomics
CIBERDEM
Tarragona, Spain

BBSRC Funded Microfluidics Engineering Resarch PhD
University College London
London, UK

Post-Doctpral Position in Mollusk Health Laboratory
UPEI
Charlottetown, Canada

Production Chemist II
Independent
Torrance, CA, USA

Research Chemist
Independent
Torrance, CA, USA

QC Analyst
Genomic Health
Redwood City, CA, USA

Research Scientist II - Biology
Gilead Sciences
Foster City, CA, USA

High Throughput Coordinator / Engineer
AJI
Houston, TX, USA

Assistant Director, Automation Services
Medarex, Inc.
Milpitas, CA, USA

3rd Annual Biomarkers Congress,14 & 15 May 2008, Manchester, UK
14 May 2008 - 15 May 2008

The conference programme will feature keynote addresses, case study presentations, panel and roundtable discussions from over 65 speakers in Biomarker Discovery and Validation, Molecular Diagnostics, Data Integration, Modelling and Bioinformatics, Imaging, Clinical Development and Toxicity Biomarkers.

Compound Management & Integrity 2008, London, UK
20 May 2008 - 22 May 2008

The 5th annual Compound Management & Integrity conference will provide you with the most current issues facing Compound Managers, Screening and Analytics professionals. Presentations from big and medium size pharmas will give you the knowledge how to update your compound logistics, automation, QC and library for lead-finding success.

Cell-Based Assays, Munich, Germany
20 May 2008 - 21 May 2008

The top line-up of expert speakers will share their latest thinking and experiences in cell-based assay design and implementation to provide you with new contacts and ideas that will help keep your assay platform at the forefront of cutting-edge technology, both in terms of usability and reliability.
  


Virtual Screening in Lead Discovery

Hugo Kubinyi, Professor of Pharmaceutical Chemistry, University of Heidelberg, speaking at Virtual discovery 2007

Cleaning Microreactors
Syrris Ltd

This application note gives hints and tips on cleaning & unblocking flow reactors, i.e. chips or tube based reactors. It is suggested that the whole document is read before attempting to unblock a reactor.

MicroReaction Technology
Published February 2007

The report presents the industry status of microreaction market, with players, their business models, products but it also describes the applications of the technology and the status of involvement of the fine chemical and pharmaceutical industry in this technology.

Automated Low Volume Dispensing Trends 2006
Published June 2006

This market report summarizes the results of a comprehensive global Pharma/Biotech and Academia web-based survey on automated low volume (nanoliter) dispensing.